Fate Therapeutics Gives Up Gains After Early Morning Surge By: Benzinga via Benzinga January 27, 2016 at 10:34 AM EST Shares of Fate Therapeutics Inc (NASDAQ: FATE), a clinical-stage biopharmaceutical company engaged in the development of programmed ... Read More >> Related Stocks: Fate Therapeutics